# V1 Empirics Check — openai/gpt-oss-120b (Variant C)

**Model:** openai/gpt-oss-120b
**Variant:** C
**Date:** 2026-03-30T16:44:56.050428

---

**1. Idea Fidelity**  
The paper follows the manifest closely. It uses the staggered municipal‑level rollout of Seguro Popular (2002‑2005) and exploits the full INEGI death micro‑data to construct cause‑specific infant‑mortality rates. All elements of the identification strategy (Callaway‑Sant’Anna staggered DiD, conditional parallel‑trend checks, placebo “non‑amenable” causes, robustness checks, and the three‑way “dose‑response’’ idea) are present. The only noticeable deviation is the treatment timing: the manifest specified *municipality‑level* enrollment dates, whereas the paper treats the rollout as *state‑level* (the same year for all municipalities within a state). This reduces the number of clusters to 32 and may weaken the variation that the manifest promised. Otherwise, the paper delivers on the research question, data sources, and methodological innovations outlined in the idea manifest.  

---

**2. Summary**  
The paper evaluates Mexico’s Seguro Popular expansion by decomposing infant mortality into “amenable’’ (treatable by basic health services) and “non‑amenable’’ causes. Using a Callaway‑Sant’Anna staggered DiD on a municipality‑year panel (1998‑2012) the author finds a modest, statistically insignificant reduction in amenable mortality (‑0.27 deaths per 1 000 live births) and no effect on non‑amenable mortality, suggesting that the program improved health‑service‑responsive deaths—particularly perinatal conditions—while leaving deaths that insurance cannot affect unchanged.  

---

**3. Essential Points**  

| # | Issue | Why it matters | What to do |
|---|-------|----------------|-----------|
| 1 | **Very few treatment clusters (state‑level timing)** | Standard errors are clustered at the state level (32 clusters). With only four treatment cohorts the estimator is highly imprecise; the paper’s main finding rests on a point estimate that is not statistically different from zero. | Re‑estimate using **municipality‑level enrollment dates** (if available) or construct a **continuous intensity measure** (coverage rate) as a treatment variable, then cluster at the municipality level (or use wild‑cluster bootstrap). This will increase power and make the inference more credible. |
| 2 | **Denominator construction (estimated births) introduces measurement error** | The author argues the error is classical and only attenuates coefficients, but the attenuation may be substantial because the outcome is a rate. Moreover, the error is common across all municipalities in a given year, potentially inflating the correlation of the error term and leading to underestimated SEs. | Use **alternative outcome specifications** that avoid the denominator: (i) log of death counts (as a Poisson/negative‑binomial), (ii) an **offset‑regression** with the estimated birth count, and (iii) a **two‑step correction** (e.g., instrument the estimated births with an external population series). Report how the ATT changes under these specifications. |
| 3 | **Parallel‑trend validation is weak** – the paper shows event‑study plots but does not present formal pre‑trend tests or the “HonestDiD’’ sensitivity analysis promised in the manifest. Without quantitative evidence the conditional parallel‑trend assumption remains questionable, especially given the known systematic poorer baseline conditions of early‑adopting states. | Provide **formal pre‑trend tests** (e.g., joint F‑test that all leads are zero) and an **HonestDiD** (Masten & Troxel 2021) robustness check that quantifies how large a violation of parallel trends would be needed to overturn the results. Also, present **placebo DiDs** using outcomes that should be unaffected (e.g., adult mortality). | Add these diagnostics to the main text or appendix; if violations are detected, consider adding **municipality‑specific linear trends** or applying the **augmented synthetic control** approach for each cohort. |

If the authors cannot address at least two of the three points above, the paper should be **rejected** for lack of credible identification.  

---

**4. Suggestions**  

Below are constructive, non‑essential recommendations that will strengthen the manuscript and increase its appeal to AER Insights readers.  

| Area | Recommendation | Rationale / Implementation |
|------|------------------|------------------------------|
| **a. Clarify Treatment Definition** | Explicitly state whether enrollment dates are *state‑level* or *municipality‑level*. If the latter exist, provide a table that lists the exact year each municipality entered the program and the corresponding coverage share. | Readers need to assess the amount of variation and the plausibility of the “absorbing’’ treatment assumption. A short appendix with the enrollment calendar (perhaps a heat‑map) would be helpful. |
| **b. Expand the Placebo Suite** | In addition to non‑amenable causes, use (i) **adult mortality** (age 15‑64) and (ii) **maternal mortality** as outcomes that should be unaffected (or only marginally affected). | Demonstrates that the observed pattern is not driven by a common time‑varying shock (e.g., improvements in water sanitation). |
| **c. Event‑Study Presentation** | Plot dynamic ATT estimates for **each cause group** (perinatal, diarrheal, respiratory, non‑amenable) with 95 % confidence bands, and report the **pre‑trend joint test** p‑value. Use the interaction‑weighted estimator of Sun & Abraham (2021) as a robustness check displayed alongside the CS‑DiD results. | Improves visual credibility of the parallel‑trend assumption and shows that the main results are not driven by the TWFE bias. |
| **d. Address Multiple Hypothesis Testing** | The paper reports several cause‑specific ATT estimates (four in Table 4). Adjust the inference (e.g., Bonferroni, Benjamini‑Hochberg) or present a **familywise‑error‑controlled “gate‑keeping’’ procedure**. | Prevents over‑interpretation of borderline significant coefficients (the perinatal ATT is close to significance). |
| **e. Mechanism Evidence** | Use available ENSANUT or ENIGH data to show that **institutional delivery rates** and **prenatal care visits** rose more in treated municipalities after SP. Present a simple DiD table or graph of these intermediate outcomes. | Strengthens the narrative that the mortality effect is driven by the supply‑ or demand‑side channels discussed in the introduction. |
| **f. Sensitivity to Cluster Choice** | Given the small number of states, report **wild‑cluster bootstrap** SEs (Cameron, Gelbach & Miller 2008) and compare them to the conventional clustered SEs. Also test clustering at the municipality level (with a multi‑way clustering correction). | Provides a robustness check against downward‑biased SEs that often arise with few clusters. |
| **g. Robustness to Alternative Mortality Definitions** | Construct **age‑specific mortality** (e.g., deaths 0‑27 days, 28‑365 days) and run the DiD separately. Also, try a **hazard‑ratio** approach using a discrete‑time survival model at the individual level (possible with the death micro‑data). | Shows that the effect is not an artifact of the chosen aggregation window. |
| **h. Discussion of External Validity** | Briefly comment on how the findings may (or may not) generalize to other LMIC health‑insurance expansions that differ in benefit package or health‑system capacity. | Positions the paper within the broader literature and helps readers assess policy relevance. |
| **i. Minor Presentation Tweaks** | • Move the long “Data Appendix’’ into a supplementary file to respect the AER Insights page limit. <br>• Use consistent notation for the treatment indicator (e.g., \(D_{st}\)). <br>• Ensure all tables have clear footnotes about the clustering level and the number of clusters. | Improves readability and compliance with journal style. |
| **j. Replication Package** | Provide a **GitHub repository** with the data‑cleaning scripts (including how the birth denominator was constructed) and the Stata/R code that implements the CS‑DiD estimator. | Facilitates replication and satisfies the AER Insights transparency requirement. |

Implementing the essential points (clusters, denominator, parallel‑trend checks) will determine whether the paper can be accepted. The additional suggestions above will polish the analysis, make the contribution more compelling, and increase the likelihood of a strong reception from both econometricians and health‑policy scholars
